Abstract: The invention relates to nutritional compositions comprising carbohydrate?sodium chloride co-crystals and to the use of these co-crystals for preparing nutritional compositions, as well as their use as carriers, fillers or stabilizers and ultimately for the acceleration of sodium chloride dissolution when other carbohydrates are present. Furthermore, the present invention is directed to a process for preparing such carbohydrate?sodium chloride co-crystals and nutritional compositions comprising such.

Abstract: The present invention relates to flavour generation. In particular the invention relates to a process for generating a flavour composition. The process comprises milling a mixture comprising flavour precursors in the solid state. A further aspect of the invention is a food product comprising the flavour composition obtainable by the process of the invention.

Abstract: The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing caftaric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid.

Abstract: The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing chicoric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing chicoric acid and/or derivatives thereof to generate tartaric and/or caffeic acid.

Abstract: A composition concentrated in ethyl esters of polyunsaturated fatty acids is prepared by mixing a refined oil rich in polyunsaturated fatty acids with ethanol in the presence of a catalyst to obtain an ethanolyzate containing a glycerol phase and fatty acid ethyl ester phase. The fatty acid ethyl ester phase is separated from the glycerol phase and mixed with urea and ethanol to form a mixture, which is cooled to form a liquid phase containing fatty acid ethyl esters and a solid phase containing insoluble inclusion complexes. The liquid phase is separated from the solid phase to obtain a fraction enriched in ethyl esters of polyunsaturated fatty acids.

Abstract: Compounds, physiologically acceptable salts of the compounds and pharmaceutical compositions containing the compounds or the salts are provided wherein the compounds have a formula of: ##STR1## in which R.sub.1 is a C.sub.2 -C.sub.5 .omega.-hydroxy-n-alkyl group or a C.sub.3 -C.sub.5 (.omega.-1)-hydroxy-n-alkyl group, R.sub.3 is a C.sub.1-C.sub.4 alkyl group, R.sub.8 is H, methyl, or ethyl and the sum of the carbon atoms in R.sub.1 and R.sub.3 is between 4 and 9 and provide inotropic (cardiotonic) activity.